A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify infectious disease therapeutics and vaccines in European institutes, for a select list of respiratory indications.
Further information
Our client wishes to identify technologies, research projects and spinout companies at any stage of development - from basic research to Phase I - focusing on the treatment of specific respiratory infections via novel therapeutics or vaccines. Primarily of focus are the...